Natural history and prognosis of pediatric PSC with updates on management.
作者信息
Fuchs Yonathan, Valentino Pamela L
机构信息
Section of Gastroenterology and Hepatology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Section of Gastroenterology and Hepatology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
出版信息
Clin Liver Dis (Hoboken). 2023 Jan 13;21(2):47-51. doi: 10.1097/CLD.0000000000000006. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Natural history and prognosis of pediatric PSC with updates on management.
Clin Liver Dis (Hoboken). 2023 Jan 13;21(2):47-51. doi: 10.1097/CLD.0000000000000006. eCollection 2023 Feb.
2
Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.
United European Gastroenterol J. 2016 Aug;4(4):562-9. doi: 10.1177/2050640615616012. Epub 2015 Oct 30.
3
Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):1025-1032. doi: 10.1080/17474124.2018.1521719. Epub 2018 Oct 1.
4
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Hepatology. 2017 Aug;66(2):518-527. doi: 10.1002/hep.29204. Epub 2017 Jun 26.
5
Recent Insights into Pediatric Primary Sclerosing Cholangitis.
Clin Liver Dis. 2022 Aug;26(3):489-519. doi: 10.1016/j.cld.2022.03.009. Epub 2022 Jun 25.
6
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5.
7
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.
J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):296-300. doi: 10.1097/00005176-200109000-00013.
8
The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):603-609. doi: 10.1097/MPG.0000000000001368.
9
Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
Hepatology. 2013 Oct;58(4):1392-400. doi: 10.1002/hep.26454. Epub 2013 Aug 13.
10
Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):404-409. doi: 10.1097/MPG.0000000000001531.
引用本文的文献
1
Good long-term outcomes of primary sclerosing cholangitis in childhood.
JHEP Rep. 2024 May 25;6(8):101123. doi: 10.1016/j.jhepr.2024.101123. eCollection 2024 Aug.
本文引用的文献
1
Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Eur Radiol. 2022 Feb;32(2):923-937. doi: 10.1007/s00330-021-08147-7. Epub 2021 Aug 6.
2
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.
Hepatology. 2021 Oct;74(4):2047-2057. doi: 10.1002/hep.31911. Epub 2021 Sep 9.
3
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.
Hepatology. 2021 Mar;73(3):1061-1073. doi: 10.1002/hep.31560.
4
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.
Hepatology. 2021 Mar;73(3):1074-1087. doi: 10.1002/hep.31393. Epub 2020 Dec 19.
5
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
Am J Gastroenterol. 2019 Dec;114(12):1878-1885. doi: 10.14309/ajg.0000000000000461.
6
A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis.
Hepatol Commun. 2019 Aug 29;3(11):1482-1495. doi: 10.1002/hep4.1421. eCollection 2019 Nov.
7
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment.
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1509-1517.e7. doi: 10.1016/j.cgh.2019.08.048. Epub 2019 Sep 4.
8
Size mismatch in deceased donor liver transplantation and its impact on graft survival.
Clin Transplant. 2019 Aug;33(8):e13662. doi: 10.1111/ctr.13662. Epub 2019 Jul 26.
9
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
Hepatol Commun. 2018 Sep 25;2(11):1369-1378. doi: 10.1002/hep4.1251. eCollection 2018 Nov.
10
Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group.
Hepatology. 2017 Nov;66(5):1675-1688. doi: 10.1002/hep.29293. Epub 2017 Sep 29.
Zotero 插件